THE SPATIAL DIFFUSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN FINLAND, 1982-1997

被引:20
|
作者
LOYTONEN, M
机构
[1] Department of Geography, University of Helsinki, Hallituskatu 11
关键词
SPATIAL DIFFUSION; EPIDEMICS; HIV; AIDS; MODELING; FINLAND;
D O I
10.1111/j.1467-8306.1991.tb01683.x
中图分类号
P9 [自然地理学]; K9 [地理];
学科分类号
0705 ; 070501 ;
摘要
Finland is one of the few countries in the world where every person found to be HIV-1 positive (suffering from any symptoms or not) is reported to the National Board of Health. This reporting and the wealth of census-based, detailed socioeconomic data available provide an excellent opportunity for the spatial analyses of the epidemic at a national level. It also provides the opportunity to create a model that considers risk factors for the population as a whole. Such a model also becomes important as the HIV-1 epidemic moves increasingly into the heterosexual population. The development of the HIV-1 epidemic in Finland, 1982-88, is first analyzed geographically using standard statistical methods. Then the growth of the HIV-1-positive population is predicted using two curves widely adopted in population dynamics, the logistic curve and the Gompertz curve. Finally, the spatial diffusion of HIV-1 in Finland, 1989-97, is predicted by applying the potential model and a simulation technique. Significant risk factors for the population as a whole include urban lifestyle, travel patterns and known risk behavior. The results suggest that the epidemic, in its initial stage in Finland, follows a hierarchical pattern demonstrated elsewhere. The simulation procedure also suggests that there is potential for an increase, in the near future, in the incidence of cases reported in hospital districts peripheral to the metropolitan region. Also expansion diffusion will begin to occur close to the epicenter. The results highlight the need for detailed data concerning the prevalence of HIV-1 and various socioeconomic variables on a spatial basis and the need for more detailed geographical analyses and modeling of the ever-growing pandemic. © 1991 Taylor & Francis Group All right reserved.
引用
收藏
页码:127 / 151
页数:25
相关论文
共 50 条
  • [21] A SIMPLIFIED METHOD FOR QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RNA IN PLASMA - CLINICAL CORRELATES
    STRICKER, RB
    ZHU, YS
    ELSWOOD, BF
    RESEARCH IN VIROLOGY, 1995, 146 (02): : 151 - 158
  • [22] PREVALENCE AND RISK DETERMINANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 (HIV-2) AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) IN WEST AFRICAN FEMALE PROSTITUTES
    KANKI, P
    MBOUP, S
    MARLINK, R
    TRAVERS, K
    HSIEH, CC
    GUEYE, A
    BOYE, C
    SANKALE, JL
    DONNELLY, C
    LEISENRING, W
    SIBY, T
    THIOR, I
    DIA, M
    GUEYE, EH
    NDOYE, I
    ESSEX, M
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 136 (07) : 895 - 907
  • [23] PROTECTION OF MACAQUES WITH A SIMIAN IMMUNODEFICIENCY VIRUS ENVELOPE PEPTIDE VACCINE BASED ON CONSERVED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEQUENCES
    SHAFFERMAN, A
    JAHRLING, PB
    BENVENISTE, RE
    LEWIS, MG
    PHIPPS, TJ
    EDENMCCUTCHAN, F
    SADOFF, J
    EDDY, GA
    BURKE, DS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) : 7126 - 7130
  • [24] A VIRION-SPECIFIC INHIBITORY MOLECULE WITH THERAPEUTIC POTENTIAL FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    MATSUDA, Z
    YU, XF
    YU, QC
    LEE, TH
    ESSEX, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) : 3544 - 3548
  • [25] FUNCTIONAL-ANALYSIS OF THE PHOSPHORYLATION SITES ON THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VPU PROTEIN
    FRIBORG, J
    LADHA, A
    GOTTLINGER, H
    HASELTINE, WA
    COHEN, EA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 8 (01): : 10 - 22
  • [26] THE INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE BY AVAROL AND AVARONE DERIVATIVES
    LOYA, S
    HIZI, A
    FEBS LETTERS, 1990, 269 (01) : 131 - 134
  • [27] ACTIVITY OF VARIOUS THIOCARBOXANILIDE DERIVATIVES AGAINST WILD-TYPE AND SEVERAL MUTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS
    BALZARINI, J
    BROUWER, WG
    FELAUER, EE
    DECLERCQ, E
    KARLSSON, A
    ANTIVIRAL RESEARCH, 1995, 27 (03) : 219 - 236
  • [28] THE ENVELOPE GLYCOPROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STIMULATES RELEASE OF NEUROTOXINS FROM MONOCYTES
    GIULIAN, D
    WENDT, E
    VACA, K
    NOONAN, CA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) : 2769 - 2773
  • [29] CHARACTERIZATION OF THE FUSION DOMAIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN GP41
    FREED, EO
    MYERS, DJ
    RISSER, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) : 4650 - 4654
  • [30] PREDICTION OF OPTIMAL PEPTIDE MIXTURES TO INDUCE BROADLY NEUTRALIZING ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    HOLLEY, LH
    GOUDSMIT, J
    KARPLUS, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) : 6800 - 6804